Research Update: Updated ICON6 Final Progression Free Survival analysis

The Lancet has recently published an update to the progression-free survival (PFS) data of theICON6 trial. (The preliminary data was first presented at the European Society of Medical Oncology congress in 2013.) ICON6 is a randomized three-arm, three stage, double-blind, placebo-controlled multi-center Gynaecologic Cancer InterGroup (GCIG) phase III trial.  ICON6 is designed to evaluate the safety and […] The post Research Update: Updated ICON6 Final Progression Free Survival analysis appeared first on Ovarian Cancer National Alliance.